KB-ND-002

N/A

Report date: 2023/05/22 10:16:46
NME

Base Information

Drug NameKB-ND-002
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTransglutaminases inhibitors
TargetsTransglutaminases
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKrisani Biosciences Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKrisani Biosciences Pte Ltd
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A